Privia Health Group, Inc. (PRVA) shares surged 5.10% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results. The company not only beat analyst estimates on key metrics but also raised its full-year outlook and announced expansion into a new market.

For Q1 2025, Privia Health reported adjusted earnings per share of $0.22, significantly outperforming the analyst consensus estimate of $0.05 and marking a 22.22% increase from the same period last year. The company's adjusted EBITDA reached $26.9 million, surpassing the IBES estimate of $23.4 million. While quarterly revenue of $480.1 million missed the analyst estimate, it still represented a solid 15.62% year-over-year growth.

Adding to the positive sentiment, Privia Health raised its full-year 2025 outlook to the mid- to high-end of its guidance ranges for all metrics, with attributed lives remaining unchanged. The company also announced its entrance into the Arizona market through a partnership with Integrated Medical Services, expanding its presence to 15 states and the District of Columbia. This strategic move, along with the strong financial performance, has bolstered investor confidence in Privia Health's growth prospects.